![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
– FDA grants priority review and assigns a Prescription Drug User Fee Act (PDUFA) target action date of January 30, 2025 – – Suzetrigine, an investigational non-opioid pain signal inhibitor, has...
Santé Canada autorise la commercialisation de TRIKAFTA(MD) (éléxacaftor/tézacaftor/ivacaftor et ivacaftor) chez les personnes atteintes de fibrose kystique âgées de...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0178 | 9.30962343096 | 0.1912 | 0.2125 | 0.1912 | 4673 | 0.20955131 | DE |
4 | -0.001 | -0.47619047619 | 0.21 | 0.2345 | 0.1808 | 9542 | 0.20609329 | DE |
12 | -0.0295 | -12.3689727463 | 0.2385 | 0.28 | 0.1808 | 14176 | 0.23615752 | DE |
26 | -0.131 | -38.5294117647 | 0.34 | 0.36 | 0.1808 | 29053 | 0.2730341 | DE |
52 | 0.029 | 16.1111111111 | 0.18 | 0.378 | 0.18 | 33055 | 0.27436709 | DE |
156 | 0.029 | 16.1111111111 | 0.18 | 0.378 | 0.18 | 33055 | 0.27436709 | DE |
260 | 0.029 | 16.1111111111 | 0.18 | 0.378 | 0.18 | 33055 | 0.27436709 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions